We are live on ! Find out more
LIAN

LianBio American Depositary Shares
LIAN

Delisted

LIAN was delisted on the 18th of March, 2024.

Back to rankings

37 hedge funds and large institutions have $319M invested in LianBio American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more funds holding

Funds holding: 36 → 37 (+1)

8% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 12

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

42% less capital invested

Capital invested by funds: $550M → $319M (-$232M)

Holders
37
Holders Change
+1
Holders Change %
+2.78%
% of All Funds
0.58%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
4
Reduced
5
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$2.93M
2
Citigroup
Citigroup
New York
+$2.2M
3
AAA
Affinity Asset Advisors
New York
+$1.04M
4
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
+$321K
5
MA
MYDA Advisors
New York
+$273K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$11M
2
AllianceBernstein
AllianceBernstein
Tennessee
-$6.96M
3
FCM
Farallon Capital Management
California
-$3.7M
4
BlackRock
BlackRock
New York
-$3.39M
5
ECM
ExodusPoint Capital Management
New York
-$736K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$209M – – –
RCM
2
RA Capital Management
Massachusetts
$28.4M – – –
VA
3
VR Adviser
New York
$20M – – –
TCM
4
Tybourne Capital Management
Hong Kong
$12.3M – – –
VVA
5
Vida Ventures Advisors
Massachusetts
$8.47M – – –
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$8.09M – – –
AllianceBernstein
7
AllianceBernstein
Tennessee
$5.63M -$6.96M -1,685,761 -53%
Viking Global Investors
8
Viking Global Investors
Connecticut
$5.57M – – –
SG
9
SCHF (GPE)
Wyoming
$3.48M – – –
Hudson Bay Capital Management
10
Hudson Bay Capital Management
Connecticut
$2.65M – – –
Citadel Advisors
11
Citadel Advisors
Florida
$2.63M +$2.93M +708,306 New
Citigroup
12
Citigroup
New York
$1.98M +$2.2M +533,795 New
LGM
13
Logos Global Management
California
$1.53M – – –
Alyeska Investment Group
14
Alyeska Investment Group
Illinois
$1.26M +$225K +54,392 +19%
AAA
15
Affinity Asset Advisors
New York
$1.21M +$1.04M +252,594 +349%
SFM
16
Sphera Funds Management
Israel
$1.02M – – –
CC
17
Casdin Capital
New York
$766K – – –
LCM
18
Laurion Capital Management
New York
$742K – – –
Millennium Management
19
Millennium Management
New York
$695K -$448K -108,521 -37%
Victory Capital Management
20
Victory Capital Management
Texas
$664K – – –
TD Asset Management
21
TD Asset Management
Ontario, Canada
$575K – – –
AA
22
ALPS Advisors
Colorado
$409K -$47.9K -11,597 -10%
MA
23
MYDA Advisors
New York
$319K +$273K +66,000 +330%
Manulife (Manufacturers Life Insurance)
24
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$278K +$321K +77,784 New
Thrivent Financial for Lutherans
25
Thrivent Financial for Lutherans
Minnesota
$184K +$204K +49,505 New
1
2

LIAN Hedge Fund Activity: Q1 2022 in Review

37 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q1 2022, worth a combined $319M — down 42% from $550M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new LIAN positions and 12 closed out — a net gain of 1 holder — while 4 added to existing stakes and 5 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $2.93M. The largest seller was Deerfield Management, exiting entirely with an estimated $11M sold.

  • 37 institutional investors held LianBio American Depositary Shares (LIAN) as of Q1 2022, up from 36 in Q4 2021.
  • Funds reported $319M of LianBio American Depositary Shares stock for Q1 2022, down 42% quarter-over-quarter.
  • 13 funds opened new LianBio American Depositary Shares positions in Q1 2022 and 12 closed out, a net change of +1 holder.
  • The largest LianBio American Depositary Shares buyer in Q1 2022 was Citadel Advisors, an estimated $2.93M added.
  • The largest LianBio American Depositary Shares seller in Q1 2022 was Deerfield Management, an estimated $11M sold.

Based on aggregated 13F filings for Q1 2022.